-
2
-
-
4043181214
-
Cancer genes and the pathways they control
-
Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature medicine 2004; 10:789-99.
-
(2004)
Nature medicine
, vol.10
, pp. 789-799
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
4
-
-
0028098165
-
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas
-
Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer research 1994; 54:794-9.
-
(1994)
Cancer research
, vol.54
, pp. 794-799
-
-
Cordon-Cardo, C.1
Latres, E.2
Drobnjak, M.3
Oliva, M.R.4
Pollack, D.5
Woodruff, J.M.6
Marechal, V.7
Chen, J.8
Brennan, M.F.9
Levine, A.J.10
-
5
-
-
14644437751
-
MDM2 is a central node in the p53 pathway: 12 years and counting
-
Bond GL, Hu W, Levine AJ. MDM2 is a central node in the p53 pathway: 12 years and counting. Current cancer drug targets 2005; 5:3-8.
-
(2005)
Current cancer drug targets
, vol.5
, pp. 3-8
-
-
Bond, G.L.1
Hu, W.2
Levine, A.J.3
-
6
-
-
0033655386
-
-
Taubert H, Koehler T, Meye A, Bartel F, Lautenschlager C, Borchert S, Bache M, Schmidt H, Wurl P. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma. Molecular medicine (Cambridge, Mass) 2000; 6:50-9.
-
Taubert H, Koehler T, Meye A, Bartel F, Lautenschlager C, Borchert S, Bache M, Schmidt H, Wurl P. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma. Molecular medicine (Cambridge, Mass) 2000; 6:50-9.
-
-
-
-
7
-
-
0026649648
-
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
-
Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69:1237-45.
-
(1992)
Cell
, vol.69
, pp. 1237-1245
-
-
Momand, J.1
Zambetti, G.P.2
Olson, D.C.3
George, D.4
Levine, A.J.5
-
8
-
-
0032475878
-
Signaling to p53: Breaking the MDM2-p53 circuit
-
Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 1998; 95:5-8.
-
(1998)
Cell
, vol.95
, pp. 5-8
-
-
Prives, C.1
-
9
-
-
0028221013
-
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway
-
Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr, Vogelstein B, Kastan MB. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 1994; 91:2684-8.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 2684-2688
-
-
Chen, C.Y.1
Oliner, J.D.2
Zhan, Q.3
Fornace Jr, A.J.4
Vogelstein, B.5
Kastan, M.B.6
-
10
-
-
0027325132
-
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
-
Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 1993; 362:857-60.
-
(1993)
Nature
, vol.362
, pp. 857-860
-
-
Oliner, J.D.1
Pietenpol, J.A.2
Thiagalingam, S.3
Gyuris, J.4
Kinzler, K.W.5
Vogelstein, B.6
-
11
-
-
34147187341
-
-
Coutts AS, La Thangue NB. Mdm2 widens its repertoire. Cell Cycle 2007; 6:827-9.
-
Coutts AS, La Thangue NB. Mdm2 widens its repertoire. Cell Cycle 2007; 6:827-9.
-
-
-
-
12
-
-
0001510491
-
The RB and p53 pathways in cancer
-
Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002; 2:103.
-
(2002)
Cancer Cell
, vol.2
, pp. 103
-
-
Sherr, C.J.1
McCormick, F.2
-
13
-
-
34248185454
-
-
Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007; 6:1006-10.
-
Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007; 6:1006-10.
-
-
-
-
14
-
-
0041696480
-
p53 - guardian of a genome's guardian?
-
Rubbi CP, Milner J. p53 - guardian of a genome's guardian? Cell Cycle 2003; 2:20-1.
-
(2003)
Cell Cycle
, vol.2
, pp. 20-21
-
-
Rubbi, C.P.1
Milner, J.2
-
15
-
-
0031583962
-
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
-
Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS letters 1997; 420:25-7.
-
(1997)
FEBS letters
, vol.420
, pp. 25-27
-
-
Honda, R.1
Tanaka, H.2
Yasuda, H.3
-
16
-
-
40549099702
-
Unlocking the Mdm2-p53 loop: Ubiquitin is the key
-
Clegg HV, Itahana K, Zhang Y. Unlocking the Mdm2-p53 loop: Ubiquitin is the key. Cell Cycle 2007; 7.
-
(2007)
Cell Cycle
, pp. 7
-
-
Clegg, H.V.1
Itahana, K.2
Zhang, Y.3
-
17
-
-
0030905284
-
Mdm2 promotes the rapid degradation of p53
-
Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296-9.
-
(1997)
Nature
, vol.387
, pp. 296-299
-
-
Haupt, Y.1
Maya, R.2
Kazaz, A.3
Oren, M.4
-
19
-
-
30344478870
-
A global map of p53 transcription-factor binding sites in the human genome
-
Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, Ng HH, Ruan Y. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207-19.
-
(2006)
Cell
, vol.124
, pp. 207-219
-
-
Wei, C.L.1
Wu, Q.2
Vega, V.B.3
Chiu, K.P.4
Ng, P.5
Zhang, T.6
Shahab, A.7
Yong, H.C.8
Fu, Y.9
Weng, Z.10
Liu, J.11
Zhao, X.D.12
Chew, J.L.13
Lee, Y.L.14
Kuznetsov, V.A.15
Sung, W.K.16
Miller, L.D.17
Lim, B.18
Liu, E.T.19
Yu, Q.20
Ng, H.H.21
Ruan, Y.22
more..
-
20
-
-
0027501841
-
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
-
Juven T, Barak Y, Zauberman A, George DL, Oren M. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 1993; 8:3411-6.
-
(1993)
Oncogene
, vol.8
, pp. 3411-3416
-
-
Juven, T.1
Barak, Y.2
Zauberman, A.3
George, D.L.4
Oren, M.5
-
23
-
-
0029131447
-
A functional p53-responsive intronic promoter is contained within the human mdm2 gene
-
Zauberman A, Flusberg D, Haupt Y, Barak Y, Oren M. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res 1995; 23:2584-92.
-
(1995)
Nucleic Acids Res
, vol.23
, pp. 2584-2592
-
-
Zauberman, A.1
Flusberg, D.2
Haupt, Y.3
Barak, Y.4
Oren, M.5
-
24
-
-
0027248782
-
Sequence-specific DNA binding by p53: Identification of target sites and lack of binding to p53-MDM2 complexes
-
Zauberman A, Barak Y, Ragimov N, Levy N, Oren M. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. The EMBO journal 1993; 12:2799-808.
-
(1993)
The EMBO journal
, vol.12
, pp. 2799-2808
-
-
Zauberman, A.1
Barak, Y.2
Ragimov, N.3
Levy, N.4
Oren, M.5
-
25
-
-
25444513462
-
Steady states and oscillations in the p53/Mdm2 network
-
Ciliberto A, Novak B, Tyson JJ. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 2005; 4:488-93.
-
(2005)
Cell Cycle
, vol.4
, pp. 488-493
-
-
Ciliberto, A.1
Novak, B.2
Tyson, J.J.3
-
26
-
-
13144294031
-
Dynamics in the p53-Mdm2 ubiquitination pathway
-
Brooks CL, Gu W. Dynamics in the p53-Mdm2 ubiquitination pathway. Cell Cycle 2004; 3:895-9.
-
(2004)
Cell Cycle
, vol.3
, pp. 895-899
-
-
Brooks, C.L.1
Gu, W.2
-
27
-
-
0029849620
-
Cancer cell cycles
-
Sherr CJ. Cancer cell cycles. Science 1996; 274:1672.
-
(1996)
Science
, vol.274
, pp. 1672
-
-
Sherr, C.J.1
-
28
-
-
0032191393
-
Tumor surveillance via the ARF-p53 pathway
-
Sherr CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev 1998; 12:2984.
-
(1998)
Genes Dev
, vol.12
, pp. 2984
-
-
Sherr, C.J.1
-
30
-
-
0028834902
-
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
-
Jones SN, Roe AE, Donehower LA, Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995; 378:206-8.
-
(1995)
Nature
, vol.378
, pp. 206-208
-
-
Jones, S.N.1
Roe, A.E.2
Donehower, L.A.3
Bradley, A.4
-
31
-
-
0029824669
-
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer
-
Sigalas I, Calvert AH, Anderson JJ, Neal DE, Lunec J. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nature medicine 1996; 2:912-7.
-
(1996)
Nature medicine
, vol.2
, pp. 912-917
-
-
Sigalas, I.1
Calvert, A.H.2
Anderson, J.J.3
Neal, D.E.4
Lunec, J.5
-
32
-
-
0029590161
-
MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell cycle arrest
-
Dubs-Poterszman MC, Tocque B, Wasylyk B. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell cycle arrest. Oncogene 1995; 11:2445-9.
-
(1995)
Oncogene
, vol.11
, pp. 2445-2449
-
-
Dubs-Poterszman, M.C.1
Tocque, B.2
Wasylyk, B.3
-
33
-
-
0032417695
-
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
-
Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci USA 1998; 95:15608-12.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 15608-15612
-
-
Jones, S.N.1
Hancock, A.R.2
Vogel, H.3
Donehower, L.A.4
Bradley, A.5
-
34
-
-
0036655060
-
Alternative and aberrant splicing of MDM2 mRNA in human cancer
-
Bartel F, Taubert H, Harris LC. Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2002; 2:9-15.
-
(2002)
Cancer Cell
, vol.2
, pp. 9-15
-
-
Bartel, F.1
Taubert, H.2
Harris, L.C.3
-
35
-
-
0842278572
-
Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific
-
Bartel F, Pinkert D, Fiedler W, Kappler M, Wurl P, Schmidt H, Taubert H. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific. International journal of oncology 2004; 24:143-51.
-
(2004)
International journal of oncology
, vol.24
, pp. 143-151
-
-
Bartel, F.1
Pinkert, D.2
Fiedler, W.3
Kappler, M.4
Wurl, P.5
Schmidt, H.6
Taubert, H.7
-
36
-
-
33750378188
-
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4
-
Chandler DS, Singh RK, Caldwell LC, Bitler JL, Lozano G. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4. Cancer research 2006; 66:9502-8.
-
(2006)
Cancer research
, vol.66
, pp. 9502-9508
-
-
Chandler, D.S.1
Singh, R.K.2
Caldwell, L.C.3
Bitler, J.L.4
Lozano, G.5
-
37
-
-
1042266626
-
An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis
-
Steinman HA, Burstein E, Lengner C, Gosselin J, Pihan G, Duckett CS, Jones SN. An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis. J Biol Chem 2004; 279:4877-86.
-
(2004)
J Biol Chem
, vol.279
, pp. 4877-4886
-
-
Steinman, H.A.1
Burstein, E.2
Lengner, C.3
Gosselin, J.4
Pihan, G.5
Duckett, C.S.6
Jones, S.N.7
-
38
-
-
0035300512
-
Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer
-
Lukas J, Gao DQ, Keshmeshian M, Wen WH, Tsao-Wei D, Rosenberg S, Press MF. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer research 2001; 61:3212-9.
-
(2001)
Cancer research
, vol.61
, pp. 3212-3219
-
-
Lukas, J.1
Gao, D.Q.2
Keshmeshian, M.3
Wen, W.H.4
Tsao-Wei, D.5
Rosenberg, S.6
Press, M.F.7
-
39
-
-
0141706686
-
Tumor promotion by Mdm2 splice variants unable to bind p53
-
Fridman JS, Hernando E, Hemann MT, de Stanchina E, Cordon Cardo C, Lowe SW. Tumor promotion by Mdm2 splice variants unable to bind p53. Cancer research 2003; 63:5703-6.
-
(2003)
Cancer research
, vol.63
, pp. 5703-5706
-
-
Fridman, J.S.1
Hernando, E.2
Hemann, M.T.3
de Stanchina, E.4
Cordon Cardo, C.5
Lowe, S.W.6
-
40
-
-
35148847384
-
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation
-
Itahana K, Mao H, Jin A, Itahana Y, Clegg HV, Lindstrom MS, Bhat KP, Godfrey VL, Evan GI, Zhang Y. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 2007; 12:355-66.
-
(2007)
Cancer Cell
, vol.12
, pp. 355-366
-
-
Itahana, K.1
Mao, H.2
Jin, A.3
Itahana, Y.4
Clegg, H.V.5
Lindstrom, M.S.6
Bhat, K.P.7
Godfrey, V.L.8
Evan, G.I.9
Zhang, Y.10
-
41
-
-
33745949757
-
Dual-site regulation of MDM2 E3-ubiquitin ligase activity
-
Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL. Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell 2006; 23:251-63.
-
(2006)
Mol Cell
, vol.23
, pp. 251-263
-
-
Wallace, M.1
Worrall, E.2
Pettersson, S.3
Hupp, T.R.4
Ball, K.L.5
-
42
-
-
0034708458
-
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
-
Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000; 275:8945-51.
-
(2000)
J Biol Chem
, vol.275
, pp. 8945-8951
-
-
Fang, S.1
Jensen, J.P.2
Ludwig, R.L.3
Vousden, K.H.4
Weissman, A.M.5
-
43
-
-
0032512057
-
Mdm2 association with p53 targets its ubiquitination
-
Fuchs SY, Adler V, Buschmann T, Wu X, Ronai Z. Mdm2 association with p53 targets its ubiquitination. Oncogene 1998; 17:2543-7.
-
(1998)
Oncogene
, vol.17
, pp. 2543-2547
-
-
Fuchs, S.Y.1
Adler, V.2
Buschmann, T.3
Wu, X.4
Ronai, Z.5
-
44
-
-
0021672811
-
Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in vitro
-
Bains W, Ponte P, Blau H, Kedes L. Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in vitro. Mol Cell Biol 1984; 4:1449-53.
-
(1984)
Mol Cell Biol
, vol.4
, pp. 1449-1453
-
-
Bains, W.1
Ponte, P.2
Blau, H.3
Kedes, L.4
-
45
-
-
0033199892
-
Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine
-
Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer research 1999; 59:4375-82.
-
(1999)
Cancer research
, vol.59
, pp. 4375-4382
-
-
Sarkaria, J.N.1
Busby, E.C.2
Tibbetts, R.S.3
Roos, P.4
Taya, Y.5
Karnitz, L.M.6
Abraham, R.T.7
-
46
-
-
0026794026
-
Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA
-
Barabas K, Sizensky JA, Faulk WP. Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA. J Biol Chem 1992; 267:9437-42.
-
(1992)
J Biol Chem
, vol.267
, pp. 9437-9442
-
-
Barabas, K.1
Sizensky, J.A.2
Faulk, W.P.3
-
47
-
-
0025220562
-
Inhibition of transcription by adriamycin is a consequence of the loss of negative superhelicity in DNA mediated by topoisomerase II
-
Tarr M, van Helden PD. Inhibition of transcription by adriamycin is a consequence of the loss of negative superhelicity in DNA mediated by topoisomerase II. Molecular and cellular biochemistry 1990; 93:141-6.
-
(1990)
Molecular and cellular biochemistry
, vol.93
, pp. 141-146
-
-
Tarr, M.1
van Helden, P.D.2
-
48
-
-
0023693619
-
Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agents
-
Auclair C, Schwaller MA, Rene B, Banoun H, Saucier JM, Larsen AK. Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agents. Anti-cancer drug design 1988; 3:133-44.
-
(1988)
Anti-cancer drug design
, vol.3
, pp. 133-144
-
-
Auclair, C.1
Schwaller, M.A.2
Rene, B.3
Banoun, H.4
Saucier, J.M.5
Larsen, A.K.6
-
49
-
-
0031926679
-
Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays
-
Guo J, Wu T, Bess J, Henderson LE, Levin JG. Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays. Journal of virology 1998; 72:6716-24.
-
(1998)
Journal of virology
, vol.72
, pp. 6716-6724
-
-
Guo, J.1
Wu, T.2
Bess, J.3
Henderson, L.E.4
Levin, J.G.5
-
50
-
-
0029879748
-
Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases
-
Rill RL, Hecker KH. Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases. Biochemistry 1996; 35:3525-33.
-
(1996)
Biochemistry
, vol.35
, pp. 3525-3533
-
-
Rill, R.L.1
Hecker, K.H.2
-
51
-
-
0034956117
-
Actinomycin D binding to unstructured, single-stranded DNA
-
Yoo H, Rill RL. Actinomycin D binding to unstructured, single-stranded DNA. J Mol Recognit 2001; 14:145-50.
-
(2001)
J Mol Recognit
, vol.14
, pp. 145-150
-
-
Yoo, H.1
Rill, R.L.2
-
53
-
-
0032491180
-
Actinomycin D inhibition of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase and nucleocapsid protein
-
Davis WR, Gabbara S, Hupe D, Peliska JA. Actinomycin D inhibition of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase and nucleocapsid protein. Biochemistry 1998; 37:14213-21.
-
(1998)
Biochemistry
, vol.37
, pp. 14213-14221
-
-
Davis, W.R.1
Gabbara, S.2
Hupe, D.3
Peliska, J.A.4
-
54
-
-
0018803120
-
Qualitative and quantitative aspects of intercalator-induced DNA strand breaks
-
Ross WE, Glaubiger D, Kohn KW. Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochimica et biophysica acta 1979; 562:41-50.
-
(1979)
Biochimica et biophysica acta
, vol.562
, pp. 41-50
-
-
Ross, W.E.1
Glaubiger, D.2
Kohn, K.W.3
-
55
-
-
0016785079
-
Continuous induction of chromatid lesions by DNA-intercalating compounds
-
Hsu TC, Pathak S, Kusyk CJ. Continuous induction of chromatid lesions by DNA-intercalating compounds. Mutation research 1975; 33:417-20.
-
(1975)
Mutation research
, vol.33
, pp. 417-420
-
-
Hsu, T.C.1
Pathak, S.2
Kusyk, C.J.3
-
56
-
-
24344449580
-
Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells
-
Balciunaite E, Spektor A, Lents NH, Cam H, Riele HT, Scime A, Rudnicki MA, Young R, Dynlacht BD. Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Molecular and Cellular Biology 2005; 25:8166-78.
-
(2005)
Molecular and Cellular Biology
, vol.25
, pp. 8166-8178
-
-
Balciunaite, E.1
Spektor, A.2
Lents, N.H.3
Cam, H.4
Riele, H.T.5
Scime, A.6
Rudnicki, M.A.7
Young, R.8
Dynlacht, B.D.9
-
57
-
-
33746659376
-
CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability
-
Tsang WY, Spektor A, Luciano DJ, Indjeian VB, Chen Z, Salisbury JL, Sanchez I, Dynlacht BD. CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability. Mol Biol Cell 2006; 17:3423-34.
-
(2006)
Mol Biol Cell
, vol.17
, pp. 3423-3434
-
-
Tsang, W.Y.1
Spektor, A.2
Luciano, D.J.3
Indjeian, V.B.4
Chen, Z.5
Salisbury, J.L.6
Sanchez, I.7
Dynlacht, B.D.8
-
58
-
-
34250794495
-
XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks
-
Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell 2007; 27:53-66.
-
(2007)
Mol Cell
, vol.27
, pp. 53-66
-
-
Acosta-Alvear, D.1
Zhou, Y.2
Blais, A.3
Tsikitis, M.4
Lents, N.H.5
Arias, C.6
Lennon, C.J.7
Kluger, Y.8
Dynlacht, B.D.9
|